Redefining the Expression and Function of the Inhibitor of Differentiation 1 in Mammary Gland Development

• Radhika Nair,

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

  ⨯
• Simon Junankar,

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

  ⨯
• Sandra O'Toole,

  Affiliations Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia, Clinical School, Sydney Medical School, Sydney University, Sydney, New South Wales, Australia, St Vincent's Clinical School, University of New South Wales, Kensington, New South Wales, Australia

  ⨯
• Jaynish Shah,

  Affiliation Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

  ⨯
• Alexander D. Borowsky,

  Affiliation Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, California, United States of America

  ⨯
• J. Michael Bishop,

  Affiliation G.W. Hooper Research Foundation, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Alexander Swarbrick

  * E-mail: a.swarbrick@garvan.org.au

  Affiliations Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia, St Vincent's Clinical School, University of New South Wales, Kensington, New South Wales, Australia

  ⨯